284 followers
.@CDifficile1 Thank you for sharing! https://t.co/u9S0p5r7GR
.@CDifficile1 Thank you for sharing! https://t.co/u9S0p5r7GR
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. - PubMed - NCBI https://t.co/kXfEiPbSDw #cdiff
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention o | BTT https://t.co/0lKicH8szD #cdiff
Bezlotoxumab: an emerging monoclonal antibody therapy for prevention o | BTT @DovePress https://t.co/Oixqu0n9KV